Visual Memory Deficits in Middle-Aged APOE ϵ4 Homozygotes Detected Using Unsupervised Cognitive Assessments

YY Lim; MP Pase; RF Buckley; N Yassi; L Bransby; C Fowler; SM Laws; CL Masters; P Maruff

Journal article

Visual Memory Deficits in Middle-Aged APOE ϵ4 Homozygotes Detected Using Unsupervised Cognitive Assessments

YY Lim, MP Pase, RF Buckley, N Yassi, L Bransby, C Fowler, SM Laws, CL Masters, P Maruff

Journal of Alzheimer S Disease | Published : 2021

DOI: 10.3233/JAD-201281

Abstract

Background: The apolipoprotein E (APOE) ϵ4 allele is associated with dose-response effects on cognitive dysfunction and dementia risk in older adults. However, its effects on cognition in middle-aged adults remains unclear. Objective: We examined effects of ϵ4 heterozygosity and homozygosity on objective and subjective cognition in middle-aged adults enrolled in the Healthy Brain Project (HBP) and in older adults from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Methods: HBP participants (1,000 non-carriers; 450 ϵ4 heterozygotes; 50 ϵ4 homozygotes) completed unsupervised assessments of the Cogstate Brief Battery (CBB), ratings of subjective cognitive function and provided a..

View full abstract

University of Melbourne Researchers

Rachel Buckley Author

Nawaf Yassi Author

Paul Maruff Author

Related Projects (1)

VASCULAR COGNITIVE RISK SCORE: QUANTIFYING THE VASCULAR BURDEN IN ALZHEIMER'S DISEASE

What causes dementia in a patient presenting to a clinic is often uncertain. While there are exciting potential treatments in the pipeline, ..

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

[ "The Healthy Brain Project (healthybrainproject. org.au) is funded by the National Health and Medical Research Council (GNT1158384, GNT1147465, GN T1111603, GNT1105576, GNT1104273, GNT1158 384, GNT1171816), the Alzheimer's Association (AARG-17-591424, AARG-18-591358, AARG-19643133), the Dementia Australia Research Foundation, the Bethlehem Griffiths Research Foundation, the Yulgilbar Alzheimer's Research Program, the National Heart Foundation of Australia (102052), and the Charleston Conference for Alzheimer's Disease. We thank our study partners (PearlArc, SRC Innovations, Cogstate Ltd and Cambridge Cognition) for their ongoing support.", "Funding for theAIBLstudywas provided in part by the study partners [Australian Commonwealth Scientific Industrial and Research Organization (CSIRO), Edith Cowan University (ECU), Florey Institute, University of Melbourne), Dementia Australia (DA), Austin Health, CogState Ltd., Sarich Institute]. The study also received support from the National Health and Medical Research Council (NHMRC).", "YY Lim is supported by an NHMRC Career Development Fellowship (GNT1162645). MP Pase is supported by a Heart Foundation Future Leader Fellowship (GNT102052). RF Buckley is supported by a National Institutes of Health K99-R00 award (K99AG061238). L Bransby is supported by a Dementia Australia Research Foundation PhD Scholarship." ]